These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20508949)

  • 1. Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.
    Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):551-5. PubMed ID: 20508949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
    González LO; González-Reyes S; Junquera S; Marín L; González L; Del Casar JM; González JM; Vizoso F
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1313-21. PubMed ID: 20127359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
    Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.
    Del Casar JM; González LO; Alvarez E; Junquera S; Marín L; González L; Bongera M; Vázquez J; Vizoso FJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):39-52. PubMed ID: 19241156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
    Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of matrix metalloproteinases and their inhibitors in prostate cancer.
    Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
    Br J Cancer; 2010 Mar; 102(5):922-9. PubMed ID: 20160732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samples.
    Fernandez-Gomez J; Escaf S; Gonzalez LO; Suarez A; Gonzalez-Reyes S; González J; Miranda O; Vizoso F
    Scand J Urol Nephrol; 2011 Apr; 45(3):171-6. PubMed ID: 21244194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.
    Lichtinghagen R; Musholt PB; Lein M; Römer A; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Jung K
    Eur Urol; 2002 Oct; 42(4):398-406. PubMed ID: 12361907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
    Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
    Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer.
    Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
    World J Urol; 2011 Oct; 29(5):657-63. PubMed ID: 20886218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
    Nagel H; Laskawi R; Wahlers A; Hemmerlein B
    Histopathology; 2004 Mar; 44(3):222-31. PubMed ID: 14987225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
    Tunuguntla R; Ripley D; Sang QX; Chegini N
    Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR; Di Silverio F; Gentile V
    Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism.
    Azuma H; Inamoto T; Sakamoto T; Kiyama S; Ubai T; Shinohara Y; Maemura K; Tsuji M; Segawa N; Masuda H; Takahara K; Katsuoka Y; Watanabe M
    Cancer Res; 2003 Dec; 63(23):8090-6. PubMed ID: 14678958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
    Del Casar JM; González-Reyes S; González LO; González JM; Junquera S; Bongera M; García MF; Andicoechea A; Serra C; Vizoso FJ
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):811-9. PubMed ID: 19916023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
    Kumamoto H; Yamauchi K; Yoshida M; Ooya K
    J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
    Brehmer B; Biesterfeld S; Jakse G
    Prostate Cancer Prostatic Dis; 2003; 6(3):217-22. PubMed ID: 12970724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.